<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04404842</url>
  </required_header>
  <id_info>
    <org_study_id>14052020</org_study_id>
    <nct_id>NCT04404842</nct_id>
  </id_info>
  <brief_title>Development of a Screening Tool for the Risk of Vitamin D Deficiency</brief_title>
  <acronym>EvidenceQ</acronym>
  <official_title>Development of a Screening Tool for the Risk of Vitamin D Deficiency</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pavia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Istituti Clinici Scientifici Maugeri SpA</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Pavia</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Since vitamin D deficiency is a condition that affects a high percentage of individuals of&#xD;
      all ages and given the attention on the possible role of the deficiency of this vitamin in&#xD;
      the development of various chronic diseases, including cardiovascular and metabolic disease&#xD;
      (obesity, insulin resistance, hypertension, diabetes) and the correlation with mortality from&#xD;
      major cardiovascular events (heart failure, myocardial infarction, sudden cardiac death,&#xD;
      stroke, atrial fibrillation and peripheral vascular disease), it is clear that in clinical&#xD;
      practice it is necessary to provide screening tools characterized by a simple use, high&#xD;
      efficacy and a low economic impact, useful to detect a possible deficiency state that has a&#xD;
      significant impact on general health and therefore provide targeted interventions for&#xD;
      diagnosis and supplementation when and if necessary. Therefore, the objective of this study&#xD;
      project is part of the broader context of supporting, with reproducible and shared scientific&#xD;
      data, operational protocols useful for the clinician to identify subjects potentially at risk&#xD;
      of vitamin D deficiency as well as directing to the diagnostic and more effective&#xD;
      therapeutic. Surveillance of vitamin D status should be a high priority in which easy-to-use&#xD;
      and interpreted tools, such as the questionnaire developed for this study, could respond to&#xD;
      the needs of early identification of subjects potentially at risk of hypovitaminosis D, thus&#xD;
      supporting the work of the clinician.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      It will be administered the questionnaire which includes specific and previously identified&#xD;
      questions useful for the purpose of the study to all patients who belong to the clinic of the&#xD;
      Dietetics and Clinical Nutrition, Internal Medicine and Endocrinology Unit, ICS Maugeri di&#xD;
      Pavia who meet the inclusion criteria and signed the Informed Consent. The blood dosage of 25&#xD;
      (OH) D will be used as a reference standard useful for achieving the purpose of the study&#xD;
      subject to the execution of diagnostic-therapeutic procedures that are beneficial to the&#xD;
      patient or performed for routine diagnostic procedures or previously prescribed by the&#xD;
      general practitioner. The collected data will be entered in the Data Collected Form together&#xD;
      with the laboratory tests.&#xD;
&#xD;
      Therefore, all patients will receive the EVIDENCE Questionnaire which includes 19 items that&#xD;
      investigate those factors that influence the production, absorption and intake of vitamin D:&#xD;
&#xD;
        -  anthropometric data (weight, height, waist circumference, BMI),&#xD;
&#xD;
        -  demographic information, such as latitude and phototype,&#xD;
&#xD;
        -  dietary intake of vitamin D,&#xD;
&#xD;
        -  health status and therapies,&#xD;
&#xD;
        -  multivitamin or vitamin D supplementation,&#xD;
&#xD;
        -  sun exposure habits according to the season, frequency and time of exposure, the body&#xD;
           parts exposed, the sunscreens use and outdoor activities.&#xD;
&#xD;
      The aim of the study is to develop a questionnaire useful in screening the adequacy of&#xD;
      vitamin D concentration in the adult population and to produce evidence of construct validity&#xD;
      and concurrent validity of the questionnaire itself.&#xD;
&#xD;
      SAMPLE SIZE: Psychometric literature suggests enrolling around 5-10 subjects for each item.&#xD;
      Considering the number of items in the questionnaire, equal to 19, the number of subjects to&#xD;
      be enrolled will be approximately 190.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 14, 2020</start_date>
  <completion_date type="Anticipated">January 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">January 31, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Construct validity (EVIDENCE Questionnaire)</measure>
    <time_frame>1 hour</time_frame>
    <description>The construct validity of the questionnaire will be assessed using exploratory factorial analysis.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Internal consistency (EVIDENCE Questionnaire)</measure>
    <time_frame>1 hour</time_frame>
    <description>The internal consistency will be evaluated with the Cronbach alpha coefficient or with the McDonald Omega coefficient.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Concurrent validity (EVIDENCE Questionnaire)</measure>
    <time_frame>1 hour</time_frame>
    <description>The concurrent validity will be assessed by comparing the results obtained with the serum 25 (OH) D dosage taken as the reference standard.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Questionnaire Scoring</measure>
    <time_frame>1 hour</time_frame>
    <description>Determine the optimal cut-off score of EvidenceQ for screening of subjects potentially at risk of vitamin D inadequacy.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">190</enrollment>
  <condition>Vitamin D Deficiency</condition>
  <condition>Vitamin D3 Deficiency</condition>
  <condition>Vitamin D</condition>
  <arm_group>
    <arm_group_label>EvidenceQ Cohort</arm_group_label>
    <description>Adult subjects, aged over 18 years, male and female.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Psychometric literature suggests that about 5-10 subjects should be recruited for each item&#xD;
        (Steiner DL et al, 2015). Considering the number of items in the questionnaire, equal to&#xD;
        19, the number of subjects to enlist will be about 190.&#xD;
&#xD;
        Consecutively recruited adult patients by the Service of Dietetics and Clinical Nutrition,&#xD;
        Unit of Internal Medicine and Endocrinology, of both sexes.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Subjects older than or equal 18 years;&#xD;
&#xD;
          -  Absence of liver pathologies;&#xD;
&#xD;
          -  Absence of kidney pathologies;&#xD;
&#xD;
          -  Absence of intestinal malabsorption syndromes;&#xD;
&#xD;
          -  Absence of bariatric surgery;&#xD;
&#xD;
          -  Absence of cancer;&#xD;
&#xD;
          -  Absence of primary hyperparathyroidism;&#xD;
&#xD;
          -  Absence of extensive dermatological pathologies (e.g. psoriasis, atopic dermatitis,&#xD;
             vitiligo)&#xD;
&#xD;
          -  Absence of supplementation with multivitamin supplements or vitamin D;&#xD;
&#xD;
          -  Absence of chronic drug therapy with: anticonvulsants, antipsychotics,&#xD;
             glucocorticoids, immunosuppressive corticosteroids, anti-retrovirals, slimming,&#xD;
             hypocolestrolemicants, laxatives (prolonged use);&#xD;
&#xD;
          -  acceptance and sign of informed consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Subjects under 18 years old;&#xD;
&#xD;
          -  Affected by liver pathologies;&#xD;
&#xD;
          -  Affected by kidney pathologies;&#xD;
&#xD;
          -  Affected by intestinal malabsorption syndromes;&#xD;
&#xD;
          -  Affected by cancer;&#xD;
&#xD;
          -  Affected by primary hyperparathyroidism;&#xD;
&#xD;
          -  Affected by extensive dermatological pathologies (e.g. psoriasis, atopic dermatitis,&#xD;
             vitiligo).&#xD;
&#xD;
          -  Candidates and/or undergoing bariatric surgery;&#xD;
&#xD;
          -  Supplementation with multivitamin or vitamin D;&#xD;
&#xD;
          -  Chronic therapy with: anticonvulsants, antipsychotics, glucocorticoids,&#xD;
             immunosuppressive corticosteroids, anti-retrovirals, slimming, hypocolestrolemizzanti,&#xD;
             laxatives (prolonged use).&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Hellas Cena</last_name>
    <role>Principal Investigator</role>
    <affiliation>Univeristy of Pavia, ICS Maugeri SpA SB</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Chiara Elena Tomasinelli</last_name>
    <phone>+39 0382 987536</phone>
    <email>chiara.tomasinelli@unipv.it</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Hellas Cena</last_name>
    <phone>0382 987542</phone>
    <email>hellas.cena@unipv.it</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Istituti Clinici Scientifici Maugeri SpA</name>
      <address>
        <city>Pavia</city>
        <state>Lombardia</state>
        <zip>27100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hellas Cena</last_name>
      <phone>+39 0382 987542</phone>
      <email>hellas.cena@unipv.it</email>
    </contact>
    <investigator>
      <last_name>Chiara Elena Tomasinelli, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Rachele De Giuseppe, Lecturer</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Giorgia Preatoni, Student</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>May 18, 2020</study_first_submitted>
  <study_first_submitted_qc>May 27, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 28, 2020</study_first_posted>
  <last_update_submitted>May 27, 2020</last_update_submitted>
  <last_update_submitted_qc>May 27, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Pavia</investigator_affiliation>
    <investigator_full_name>Hellas Cena</investigator_full_name>
    <investigator_title>Tenured researcher</investigator_title>
  </responsible_party>
  <keyword>Vitamin D</keyword>
  <keyword>Cholecalciferol</keyword>
  <keyword>Deficiency</keyword>
  <keyword>Inadeguacy</keyword>
  <keyword>Screening</keyword>
  <keyword>Questionnaire</keyword>
  <keyword>Survey</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamin D Deficiency</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

